US Stock MarketDetailed Quotes

ELOX Eloxx Pharmaceuticals

Watchlist
  • 0.000
  • +0.000+9900.00%
15min DelayClose Nov 22 16:00 ET
314.34Market Cap0.00P/E (TTM)

Eloxx Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-49.08%3.64M
-59.79%4.14M
-49.94%5.48M
-47.86%34.42M
-48.17%6.03M
-30.29%7.14M
-71.18%10.3M
30.18%10.95M
124.27%66.02M
101.14%11.63M
Selling and administrative expenses
5.53%2.39M
-31.87%1.8M
-34.68%2M
-47.71%10.69M
-26.55%2.73M
-55.07%2.26M
-64.04%2.65M
-29.65%3.05M
37.73%20.45M
18.33%3.72M
-General and administrative expense
5.53%2.39M
-31.87%1.8M
-34.68%2M
-47.71%10.69M
-26.55%2.73M
-55.07%2.26M
-64.04%2.65M
-29.65%3.05M
37.73%20.45M
18.33%3.72M
Research and development costs
-74.39%1.25M
-69.44%2.34M
-55.84%3.49M
-47.93%23.73M
-58.33%3.3M
-6.33%4.88M
-73.04%7.65M
93.94%7.9M
212.33%45.57M
199.70%7.91M
Operating profit
49.08%-3.64M
59.79%-4.14M
49.94%-5.48M
47.86%-34.42M
48.17%-6.03M
30.29%-7.14M
71.18%-10.3M
-30.18%-10.95M
-124.27%-66.02M
-101.14%-11.63M
Net non-operating interest income expense
43.57%-215K
59.86%-173K
18.72%-317K
-33.89%-1.68M
9.09%-440K
-102.66%-381K
-35.11%-431K
-50.00%-390K
-16.70%-1.25M
-52.20%-484K
Non-operating interest income
-81.48%20K
147.83%57K
1,100.00%168K
3,325.00%274K
603.57%141K
200.00%108K
--23K
--14K
-97.63%8K
-2,900.00%-28K
Non-operating interest expense
-51.94%235K
-49.34%230K
20.05%485K
54.81%1.95M
27.41%581K
118.30%489K
42.32%454K
55.38%404K
-10.65%1.26M
42.95%456K
Other net income (expense)
1,633.33%260K
-125.69%-28K
-55.23%-430K
-94.65%29K
520.83%149K
-97.26%15K
1,190.00%109K
-1,285.00%-277K
113.32%542K
188.89%24K
Gain on sale of security
1,566.67%250K
-132.14%-36K
91.34%-24K
-2,500.00%-48K
200.00%72K
87.50%15K
1,220.00%112K
-1,285.00%-277K
104.00%2K
900.00%24K
Special income (charges)
--255K
--0
---406K
--0
--0
--0
--0
--0
113.44%540K
--0
-Less:Other special charges
----
----
--406K
----
----
----
----
----
---540K
--0
-Gain on sale of property,plant,equipment
--255K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
---245K
366.67%8K
----
--77K
----
----
---3K
----
----
----
Income before tax
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
70.55%-10.62M
-33.66%-11.62M
-92.98%-66.73M
-97.32%-12.09M
Income tax
Net income
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
70.55%-10.62M
-33.66%-11.62M
-92.98%-66.73M
-97.32%-12.09M
Net income continuous Operations
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
70.55%-10.62M
-33.66%-11.62M
-92.98%-66.73M
-97.32%-12.09M
Minority interest income
Net income attributable to the parent company
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
70.55%-10.62M
-33.66%-11.62M
-92.98%-66.73M
-97.32%-12.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
70.55%-10.62M
-33.66%-11.62M
-92.98%-66.73M
-97.32%-12.09M
Basic earnings per share
62.25%-1.31
60.00%-1.96
46.27%-2.88
56.36%-16.65
47.86%-2.92
21.14%-3.47
77.31%-4.9
39.09%-5.36
-10.90%-38.15
6.67%-5.6
Diluted earnings per share
62.25%-1.31
60.00%-1.96
46.27%-2.88
56.36%-16.65
47.86%-2.92
21.14%-3.47
77.31%-4.9
39.09%-5.36
-10.90%-38.15
6.67%-5.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -49.08%3.64M-59.79%4.14M-49.94%5.48M-47.86%34.42M-48.17%6.03M-30.29%7.14M-71.18%10.3M30.18%10.95M124.27%66.02M101.14%11.63M
Selling and administrative expenses 5.53%2.39M-31.87%1.8M-34.68%2M-47.71%10.69M-26.55%2.73M-55.07%2.26M-64.04%2.65M-29.65%3.05M37.73%20.45M18.33%3.72M
-General and administrative expense 5.53%2.39M-31.87%1.8M-34.68%2M-47.71%10.69M-26.55%2.73M-55.07%2.26M-64.04%2.65M-29.65%3.05M37.73%20.45M18.33%3.72M
Research and development costs -74.39%1.25M-69.44%2.34M-55.84%3.49M-47.93%23.73M-58.33%3.3M-6.33%4.88M-73.04%7.65M93.94%7.9M212.33%45.57M199.70%7.91M
Operating profit 49.08%-3.64M59.79%-4.14M49.94%-5.48M47.86%-34.42M48.17%-6.03M30.29%-7.14M71.18%-10.3M-30.18%-10.95M-124.27%-66.02M-101.14%-11.63M
Net non-operating interest income expense 43.57%-215K59.86%-173K18.72%-317K-33.89%-1.68M9.09%-440K-102.66%-381K-35.11%-431K-50.00%-390K-16.70%-1.25M-52.20%-484K
Non-operating interest income -81.48%20K147.83%57K1,100.00%168K3,325.00%274K603.57%141K200.00%108K--23K--14K-97.63%8K-2,900.00%-28K
Non-operating interest expense -51.94%235K-49.34%230K20.05%485K54.81%1.95M27.41%581K118.30%489K42.32%454K55.38%404K-10.65%1.26M42.95%456K
Other net income (expense) 1,633.33%260K-125.69%-28K-55.23%-430K-94.65%29K520.83%149K-97.26%15K1,190.00%109K-1,285.00%-277K113.32%542K188.89%24K
Gain on sale of security 1,566.67%250K-132.14%-36K91.34%-24K-2,500.00%-48K200.00%72K87.50%15K1,220.00%112K-1,285.00%-277K104.00%2K900.00%24K
Special income (charges) --255K--0---406K--0--0--0--0--0113.44%540K--0
-Less:Other special charges ----------406K-----------------------540K--0
-Gain on sale of property,plant,equipment --255K------------------0----------------
Other non- operating income (expenses) ---245K366.67%8K------77K-----------3K------------
Income before tax 52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M70.55%-10.62M-33.66%-11.62M-92.98%-66.73M-97.32%-12.09M
Income tax
Net income 52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M70.55%-10.62M-33.66%-11.62M-92.98%-66.73M-97.32%-12.09M
Net income continuous Operations 52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M70.55%-10.62M-33.66%-11.62M-92.98%-66.73M-97.32%-12.09M
Minority interest income
Net income attributable to the parent company 52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M70.55%-10.62M-33.66%-11.62M-92.98%-66.73M-97.32%-12.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M70.55%-10.62M-33.66%-11.62M-92.98%-66.73M-97.32%-12.09M
Basic earnings per share 62.25%-1.3160.00%-1.9646.27%-2.8856.36%-16.6547.86%-2.9221.14%-3.4777.31%-4.939.09%-5.36-10.90%-38.156.67%-5.6
Diluted earnings per share 62.25%-1.3160.00%-1.9646.27%-2.8856.36%-16.6547.86%-2.9221.14%-3.4777.31%-4.939.09%-5.36-10.90%-38.156.67%-5.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data